Merck (MRK) Molnupiravir Pill Could Change the Fight Against Covid - Bloomberg
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited
Merck Pulls Ahead Renewable Energy Goal by 15 Years, Aims for Carbon Neutrality by 2025 - ESG Today
Gardasil pulls in $1.5bn, driving vaccines for Merck - BioProcess InsiderBioProcess International
Merck's COVID-19 antiviral pill is now approved in the U.K. : Coronavirus Updates : NPR
Merck pauses Russia investments, to supply essential medicines | Reuters
Merck's Keytruda Pulled for SCLC as FDA Re-Evaluates Past Accelerated Approvals | BioSpace
Merck & Co. - Wikipedia
Merck Sells Covid Pill for 40 Times What It Costs to Make
Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators' review time only one benefit | Fierce Pharma
Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain vaccine | Fierce Pharma
Merck pulls out of license deal with Ono Pharma for MS drug ceralifimo
Merck's Covid Treatment Pill: What to Know About Molnupiravir - The New York Times
Merck & Co - Drug Company History, Products & Lawsuits
Fresenius pulls off sterile injectables double whammy, snags Akorn as well as Merck KGaA's biosimilars business | Fierce Pharma
Merck-Pulls-Plug-Painkiller-Vioxx
Merck leads rivals in novel drug approvals | Evaluate
